NCT00403559.

Trial name or title	A 4 week randomized double‐blind parallel group active comparator controlled study of Elidel for the treatment of seborrheic dermatitis
Methods	This is a randomised, double‐blind, parallel group study
Participants	18 years or older with seborrhoeic dermatitis
Interventions	Pimecrolimus cream 1% Ketoconazole cream 2%
Outcomes	Primary outcome/s of the trial The change of IGA from baseline to week 1 Secondary outcome/s of the trial Per cent of participants with facial clearance
Starting date	January 2007
Contact information	Joseph F Fowler Jr, Dermatology Specialists Research
Notes	Completed in January 2009, but no publications provided. Database accessed on 17 December 2012